Skip to main content

FDA Registration Assistance

FDA Import Alert 54-07 germanium supplements
FDA Import Alerts · Supplements
Last updated:

FDA Import Alert 54-07: Germanium Supplements

Import Alert 54-07 lets FDA detain any germanium product offered for human consumption without examining it, including bulk entries with no label. FDA links chronic germanium use to kidney injury and death. Products for semiconductor or other non-human uses can be released, and only firms on the Green List are exempt.

Short answer: FDA Import Alert 54-07 allows detention without physical examination of germanium products offered for human consumption, such as dietary supplements and unlabeled bulk entries, because germanium has caused kidney injury and death with chronic use, even at recommended levels. Products shown to be for non-human uses, such as semiconductors, are released. Only products on the Green List are exempt, and a firm applies for it through Importalerts2@fda.hhs.gov.

Listed on 54-07? Send us the product, intended use and shipment details. We review your options and prepare the request.

Get a 54-07 Case Review
At a Glance

Import Alert 54-07 Basics

ItemImport Alert 54-07
Official titleDWPE of Germanium Supplements for Human Consumption
ScopeAll germanium products for human consumption, including bulk
ChargeSection 402(a)(1), refusal under 801(a)(3); code POISONOUS
ExceptionNon-human uses, such as semiconductors
Green ListYes; one firm in Korea is listed
Green List contactImportalerts2@fda.hhs.gov

Details follow the current text of Import Alert 54-07, published March 5, 2026.

Listed Products

Germanium Products Named in 54-07

Germanium sesquioxide

Also sold as GE-132 and GE-OXY-132.

Germanium-lactate-citrate

Named in the alert.

Vitamin "O"

Sold as an oxygen supplement.

Pro-Oxygen

Named in the alert.

Nutrigel 132

Named in the alert.

Immune Multiple and Germax

Named in the alert.

Release and Removal

Two Tracks: Releasing a Shipment vs Leaving the List

Release one shipment

Evidence that the product is for a use other than human consumption, such as semiconductor manufacturing, or private lab analysis of representative samples, sent to the FDA Division compliance office named in the notice. FDA may verify where the product goes.

Removal from the Red List

Information showing the conditions behind the violation are resolved, sent to the Division of Import Operations through Importalerts2@fda.hhs.gov to be considered for the Green List, under RPM Chapter 9-8.

Removal Evidence

What a Strong 54-07 Request Includes

  • The product, its germanium form and the intended use.
  • For non-human use: purchase orders, end-user details and technical specs.
  • For the Green List: product formulation and safety information.
  • Labels and labeling with no disease claims.
  • Lab analysis, where relevant.
How It Works

Our Import Alert 54-07 Process

1
Review the productWe check the germanium form, labeling and intended use.
2
Choose the pathWe decide between a non-human use release and a Green List request.
3
Gather evidenceWe assemble end-use records or safety and formulation data.
4
Evidence packageWe organize the submission for FDA.
5
Request and follow-upWe send it to FDA and answer its questions.

FDA's framework is in RPM Chapter 9-8; FDA removal guidance explains what a request should include.

Related Help

Import Alert Resources

Import Alert Removal

Removal help for food and supplements.

Dietary Supplements

Supplement registration and labeling.

Import Alert 54-16

Supplements with hidden drugs.

Import Alert 54-10

Aristolochic acid in supplements.

Supplement Label Review

Check claims and ingredient labeling.

Release a Held Shipment

FDA hold statuses and release steps.

Start With the Listing

Get Help With Import Alert 54-07

We review the product and intended use, choose the right path and prepare the release or Green List request. We are an independent compliance firm, not FDA or a law firm, and no one can guarantee FDA's decision.

  • Custom-scoped quote based on your listing and products.
  • Exporters, manufacturers and U.S. importers.
  • Agree the scope and pricing before any paid work begins.

Contact our specialists, email info@fdaregistrationassistance.com, or call +1 (928) 275-8333. Import alert removal · Supplement services · Contact.

Get a 54-07 Case Review

FDA Registration Assistance is a private consulting firm, not FDA or any government agency. FDA registration is not FDA approval, clearance or certification.

FAQ

Frequently Asked Questions — Import Alert 54-07

What is FDA Import Alert 54-07?

Import Alert 54-07 is titled "Detention Without Physical Examination of Germanium Supplements for Human Consumption." It lets FDA detain germanium products offered for human consumption without examining each shipment.

Why does FDA detain germanium supplements?

FDA says germanium is a nonessential trace element that has caused kidney injury (nephrotoxicity) and death when used chronically by humans, even at recommended levels of use.

Which products does Import Alert 54-07 cover?

All germanium products offered for human consumption, including unlabeled bulk entries, except products on the Green List. Named examples include germanium sesquioxide, germanium-lactate-citrate, GE-132, GE-OXY-132, Vitamin "O", Pro-Oxygen, Nutrigel 132, Immune Multiple and Germax.

What is the charge under Import Alert 54-07?

The product appears to contain a poisonous or deleterious substance that may render it injurious to health, making it adulterated under section 402(a)(1) and subject to refusal under section 801(a)(3). The OASIS code is POISONOUS.

Does 54-07 apply to germanium for semiconductors?

No. The alert applies only to products for human consumption. If the importer shows the product is for another use, such as the semiconductor industry, the entry should be released, and FDA may follow up to verify where it goes.

Is 54-07 a firm list or a product-wide alert?

It is product-wide. It applies to germanium products from all countries, unless the product is on the Green List.

Who is on the 54-07 Green List?

The alert lists Geranti Pharmaceutical Ltd. in the Republic of Korea, for Geranti Bio-Germanium and Geranti Bio-Ge Yeast.

How can a detained 54-07 shipment be released?

The owner or consignee can show the product is for a use other than human consumption, or provide private lab analysis of representative samples, sent to the FDA Division compliance office named in the notice. FDA may collect its own audit samples.

How do I get a product added to the 54-07 Green List?

Send information showing the conditions behind the violation are resolved, so FDA can be confident future shipments will comply. The Division of Import Operations reviews requests case by case with FDA's food program. Email Importalerts2@fda.hhs.gov, following RPM Chapter 9-8.

What if my germanium product makes disease claims?

Products whose labeling claims to diagnose, cure, mitigate, treat or prevent disease are referred to FDA's drug center under Import Alert 66-41. Supplements cannot make disease claims. See our dietary supplements page.

Can germanium be sold as a dietary supplement in the U.S.?

Germanium products for human consumption are detained under this alert unless they are on the Green List. Talk to us before importing any germanium ingredient for food or supplement use.

Who do I contact at FDA about Import Alert 54-07?

Green List requests go to Importalerts2@fda.hhs.gov. The alert lists the Division of Import Operations at (301) 796-0356 or Imports@fda.hhs.gov, FDAPRIVATELABIMPORTALERTS@fda.hhs.gov for analytical methods, and HFP-OCE-Imports@fda.hhs.gov for policy questions.

What does the U.S. importer need to do?

Importers must keep a Foreign Supplier Verification Program that covers germanium where it is a known or reasonably foreseeable hazard, with supplier verification and testing for higher-risk products. See our FSVP service.

Can you guarantee removal from Import Alert 54-07?

No. FDA makes every removal decision. We are an independent compliance firm, not FDA or a law firm. We help you build a complete, well-documented request.

HM
Reviewed By Hector Matos, Senior Regulatory Compliance Specialist · 15+ years FDA compliance experience · Updated October 2026
Discuss Your Project

Request an Import Alert 54-07 Case Review

Tell us what your company makes, sells, or distributes, where each product is manufactured or packed, your U.S. importer or buyer arrangement, label readiness, and target shipment date.

Submitting this inquiry does not purchase a service or authorize paid work. Our team can discuss the scope and required materials before you commission assistance. Fields marked with an asterisk are required.

Please do not include payment details, medical records, or other sensitive information. You can also email our team or call +1 (928) 275-8333.